1 min read

Veristat to Attend the European Society for Medical Oncology (ESMO) Conference

website-image_esmoJoin Veristat and other Oncology researchers, clinicians and patients at the ESMO 2016 Conference, focused on finding the most effective cancer treatment solutions available today.   ESMO 2016 offers a top-notch scientific and educational program created by international experts in oncology.  Some key topic areas include:

  • The Immunotherapy of Cancer
  • Adapting Clinical Trials to Tumor Biology
  • Rare Cancers
  • Patient Networks Driving Cancer Research
  • Cancer Indication Specific Updates and Treatment Breakthroughs
  • And, more

Schedule a Meeting with Veristat

Veristat’s Theresa Bruce and Kath Clayton will be attending ESMO and will be on hand to discuss how Veristat can help you design and execute your cancer trials throughout Europe and North America.

Veristat has helped clients run hundreds of oncology clinical trials for novel drugs, biologics, vaccines, immuno-therapies and diagnostics. We know that even the simplest of clinical trials tasks are much more complex and requires skilled expertise to complete.   Schedule a time to speak with Veristat at ESMO about the challenges you are trying to overcome with your oncology program.

Schedule-a-Meeting-Button-535x165

Share This Event:

   

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...

1 min read

Swiss Biotech Day

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

With nearly 30 years of experience in clinical trial...